End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.57 CNY | -0.81% |
|
-1.04% | -34.18% |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 3,172 | 2,639 |
Enterprise Value (EV) 1 | 2,506 | 2,041 |
P/E ratio | 56.2 x | 62 x |
Yield | 0.45% | 0.61% |
Capitalization / Revenue | 5.24 x | 3.5 x |
EV / Revenue | 4.14 x | 2.71 x |
EV / EBITDA | 36.7 x | 22.8 x |
EV / FCF | -16,329,447 x | -21,137,068 x |
FCF Yield | -0% | -0% |
Price to Book | 2.18 x | 1.78 x |
Nbr of stocks (in thousands) | 202,678 | 202,678 |
Reference price 2 | 15.65 | 13.02 |
Announcement Date | 23-03-13 | 24-03-25 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 227.9 | 231.9 | 262.7 | 585 | 605.4 | 753.3 |
EBITDA 1 | 20.84 | 20.14 | 53.88 | 81.62 | 68.26 | 89.71 |
EBIT 1 | 16.1 | 14.51 | 42.54 | 45.22 | 26.43 | 36.11 |
Operating Margin | 7.06% | 6.26% | 16.2% | 7.73% | 4.37% | 4.79% |
Earnings before Tax (EBT) 1 | 8.728 | 10.25 | 35.66 | 38.34 | 52.58 | 53.29 |
Net income 1 | 8.707 | 10.06 | 30.38 | 35.27 | 47.03 | 43.55 |
Net margin | 3.82% | 4.34% | 11.57% | 6.03% | 7.77% | 5.78% |
EPS 2 | 0.1087 | 0.1100 | 0.3300 | 0.2300 | 0.2785 | 0.2100 |
Free Cash Flow | - | -92.62 | -130.4 | -423.2 | -153.5 | -96.56 |
FCF margin | - | -39.94% | -49.66% | -72.34% | -25.35% | -12.82% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | 0.0700 | 0.0800 |
Announcement Date | 22-03-11 | 22-03-11 | 22-03-11 | 22-06-30 | 23-03-13 | 24-03-25 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 11.8 | 104 | - | 95.2 | - | - |
Net Cash position 1 | - | - | 173 | - | 666 | 598 |
Leverage (Debt/EBITDA) | 0.5653 x | 5.174 x | - | 1.167 x | - | - |
Free Cash Flow | - | -92.6 | -130 | -423 | -153 | -96.6 |
ROE (net income / shareholders' equity) | - | 8.31% | 8.15% | 5.54% | 4.47% | 2.97% |
ROA (Net income/ Total Assets) | - | 3.24% | 3.56% | 2.4% | 1.06% | 1.13% |
Assets 1 | - | 310.2 | 852.4 | 1,467 | 4,429 | 3,840 |
Book Value Per Share 2 | 1.450 | 1.380 | 4.070 | 4.300 | 7.160 | 7.310 |
Cash Flow per Share 2 | 0.5800 | 0.5700 | 3.910 | 1.640 | 4.630 | 4.220 |
Capex 1 | 38.7 | 116 | 198 | 309 | 225 | 214 |
Capex / Sales | 17% | 49.88% | 75.41% | 52.9% | 37.21% | 28.42% |
Announcement Date | 22-03-11 | 22-03-11 | 22-03-11 | 22-06-30 | 23-03-13 | 24-03-25 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.18% | 239M | |
+22.50% | 69.45B | |
-6.76% | 45.71B | |
+24.23% | 44.6B | |
+31.15% | 27.77B | |
+8.08% | 19.08B | |
+15.06% | 17.04B | |
-10.27% | 15.22B | |
-26.60% | 14.77B | |
-29.69% | 12.05B |
- Stock Market
- Equities
- 688203 Stock
- Financials Zhejiang Hisun Biomaterials Co.Ltd.